Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Den nåværende markedsprisen på Moderna Inc er 1 411,6 kr, med et 24-timers handelsvolum på 221,93M kr. Eiendelens markedsverdi er 563,56B kr, etter en endring på 1.92% det siste døgnet.
Tokenisert Moderna Inc handles til 1 405,22 kr, med en tokenisert markedsverdi på 7,67M kr og et 24-timers handelsvolum på 43,99M kr. Den tokeniserte eiendelen har beveget seg 11.73% i løpet av de siste 24 timene.